NO996035L - Fremgangsmåte for behandling av diaré og for å eliminere enkelte bakteriepopulasjoner fra tykktarmen - Google Patents

Fremgangsmåte for behandling av diaré og for å eliminere enkelte bakteriepopulasjoner fra tykktarmen

Info

Publication number: NO996035L
Authority: NO; Norway
Prior art keywords: diarrhea; procedure; treatment; large intestine; bacterial populations
Prior art date: 1997-06-09

Application number

NO996035A

Other languages

English (en)

Norwegian (no)

Other versions

NO996035D0 (no

Inventor

Beth P Goldstein

Original Assignee

Ambi Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-09

Filing date

1999-12-08

Publication date

1999-12-08

1999-12-08 Application filed by Ambi Inc filed Critical Ambi Inc

1999-12-08 Publication of NO996035D0 publication Critical patent/NO996035D0/no

1999-12-08 Publication of NO996035L publication Critical patent/NO996035L/no

Links

206010012735 Diarrhoea Diseases 0.000 title 1
230000001580 bacterial effect Effects 0.000 title 1
210000002429 large intestine Anatomy 0.000 title 1
108010062877 Bacteriocins Proteins 0.000 abstract 1
241000193163 Clostridioides difficile Species 0.000 abstract 1
DWPCPZJAHOETAG-IMJSIDKUSA-N L-lanthionine Chemical compound OC(=O)[C@@H](N)CSC[C@H](N)C(O)=O DWPCPZJAHOETAG-IMJSIDKUSA-N 0.000 abstract 1
108010053775 Nisin Proteins 0.000 abstract 1
NVNLLIYOARQCIX-MSHCCFNRSA-N Nisin Chemical compound N1C(=O)[C@@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](NC(=O)C(=C/C)/NC(=O)[C@H](N)[C@H](C)CC)CSC[C@@H]1C(=O)N[C@@H]1C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(NCC(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)NCC(=O)N[C@H](CS[C@@H]2C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(N[C@H](C)C(=O)N[C@@H]3C(=O)N[C@@H](C(N[C@H](CC=4NC=NC=4)C(=O)N[C@H](CS[C@@H]3C)C(=O)N[C@H](CO)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H](CC=3NC=NC=3)C(=O)N[C@H](C(C)C)C(=O)NC(=C)C(=O)N[C@H](CCCCN)C(O)=O)=O)CS[C@@H]2C)=O)=O)CS[C@@H]1C NVNLLIYOARQCIX-MSHCCFNRSA-N 0.000 abstract 1
108010059993 Vancomycin Proteins 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
210000001072 colon Anatomy 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
DWPCPZJAHOETAG-UHFFFAOYSA-N meso-lanthionine Natural products OC(=O)C(N)CSCC(N)C(O)=O DWPCPZJAHOETAG-UHFFFAOYSA-N 0.000 abstract 1
239000004309 nisin Substances 0.000 abstract 1
235000010297 nisin Nutrition 0.000 abstract 1
MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 abstract 1
229960003165 vancomycin Drugs 0.000 abstract 1
MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Inorganic Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Plant Substances (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

NO996035A 1997-06-09 1999-12-08 Fremgangsmåte for behandling av diaré og for å eliminere enkelte bakteriepopulasjoner fra tykktarmen NO996035L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US4923697P	1997-06-09	1997-06-09
US08/950,225 US5985823A (en)	1997-06-09	1997-10-14	Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
PCT/US1998/011820 WO1998056398A2 (en)	1997-06-09	1998-06-08	A method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon

Publications (2)

Publication Number	Publication Date
NO996035D0 NO996035D0 (no)	1999-12-08
NO996035L true NO996035L (no)	1999-12-08

Family

ID=26726981

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO996035A NO996035L (no)	1997-06-09	1999-12-08	Fremgangsmåte for behandling av diaré og for å eliminere enkelte bakteriepopulasjoner fra tykktarmen

Country Status (16)

Country	Link
US (1)	US5985823A (de)
EP (1)	EP0983079B1 (de)
JP (1)	JP2002504906A (de)
CN (1)	CN1264306A (de)
AT (1)	ATE289821T1 (de)
AU (1)	AU7826298A (de)
BR (1)	BR9810861A (de)
CA (1)	CA2291645A1 (de)
DE (1)	DE69829179T2 (de)
IL (1)	IL132933A0 (de)
NO (1)	NO996035L (de)
PL (1)	PL337779A1 (de)
PT (1)	PT983079E (de)
SK (1)	SK169499A3 (de)
TW (1)	TW505515B (de)
WO (1)	WO1998056398A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL1013861C2 (nl) *	1999-12-15	2001-06-18	Stichting Tech Wetenschapp	Toepassing van Nisine of derivaat daarvan.
SI21221A (sl) *	2002-06-21	2003-12-31	LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d.	Hitro razpadljive tablete
AU2003296937A1 (en) *	2002-12-10	2004-06-30	Biosynexus Incorporated	Topical anti-infective formulations
US7326683B2 (en) *	2004-05-06	2008-02-05	Molichem Medicines, Inc.	Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions
ITMI20041295A1 (it) *	2004-06-25	2004-09-25	Cosmo Spa	Composizioni farmaceutiche antimicrobiche orali
CN102847141A (zh) *	2005-09-28	2013-01-02	文特里亚生物科学公司	用于肠道病症和/或补水的口服制剂
GB0600928D0 (en) *	2006-01-17	2006-02-22	Novacta Biosystems Ltd	Improvements relating to lantibiotics
EP1994117A4 (de) *	2006-02-08	2010-05-26	Biosynexus Inc	Neutralisierung von bakteriensporen
ITMI20060678A1 (it) *	2006-04-06	2007-10-07	Sanofi Aventis Otc S P A	Composto peptidico ad attivita' b iologica sua preparazione e sue applicazioni
GB0714030D0 (en) *	2007-07-18	2007-08-29	Novacta Biosystems Ltd	The use of type-B lantibiotic-based compounds having antimicrobial activity
GB0714029D0 (en) *	2007-07-18	2007-08-29	Novacta Biosystems Ltd	Lantibiotic-based compounds having antimicrobial activity
WO2009037264A2 (en) *	2007-09-17	2009-03-26	Da Volterra	Colonic delivery of antimicrobial agents
ES2520165T3 (es)	2009-01-14	2014-11-11	Novacta Biosystems Limited	Derivados de desoxiactagardina
WO2010089544A1 (en)	2009-02-04	2010-08-12	Novacta Biosystems Limited	Actagardine derivatives
GB201001688D0 (en)	2010-02-02	2010-03-17	Novacta Biosystems Ltd	Compounds
EP2627320A1 (de)	2010-07-14	2013-08-21	Novacta Biosystems Limited	Formulierung mit einem typ-b-lantibiotikum
GB201013513D0 (en)	2010-08-11	2010-09-22	Novacta Biosystems Ltd	Formulations
JP2016512428A (ja) *	2013-03-14	2016-04-28	アビッドバイオティクスコーポレイション	ディフォシン及びその使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5304540A (en) *	1988-06-22	1994-04-19	Applied Microbiology, Inc.	Pharmaceutical bacteriocin compositions and methods for using the same
US5260271A (en) *	1988-06-22	1993-11-09	Applied Microbiology, Inc.	Nisin compositions for use as enhanced broad range bactericides
IL104364A (en) *	1992-01-17	1997-09-30	Applied Microbiology	Pharmaceutical compositions containing bacteriocins
BR9609281A (pt) *	1995-06-23	1999-06-15	Ambi Inc	Método para o controle de bactérias gram-positivas resistentes a antibióticos e tratamento de infecções
US5910479A (en) *	1996-10-18	1999-06-08	Ambi Inc.	Method for the treatment of Streptococcus pneumoniae infection

1997
- 1997-10-14 US US08/950,225 patent/US5985823A/en not_active Expired - Lifetime
1998
- 1998-06-06 TW TW087108997A patent/TW505515B/zh not_active IP Right Cessation
- 1998-06-08 PL PL98337779A patent/PL337779A1/xx not_active IP Right Cessation
- 1998-06-08 JP JP50303799A patent/JP2002504906A/ja not_active Ceased
- 1998-06-08 SK SK1694-99A patent/SK169499A3/sk unknown
- 1998-06-08 IL IL13293398A patent/IL132933A0/xx unknown
- 1998-06-08 CN CN98805829A patent/CN1264306A/zh active Pending
- 1998-06-08 CA CA002291645A patent/CA2291645A1/en not_active Abandoned
- 1998-06-08 DE DE69829179T patent/DE69829179T2/de not_active Expired - Fee Related
- 1998-06-08 PT PT98926418T patent/PT983079E/pt unknown
- 1998-06-08 BR BR9810861-1A patent/BR9810861A/pt not_active Application Discontinuation
- 1998-06-08 WO PCT/US1998/011820 patent/WO1998056398A2/en not_active Ceased
- 1998-06-08 AU AU78262/98A patent/AU7826298A/en not_active Abandoned
- 1998-06-08 AT AT98926418T patent/ATE289821T1/de not_active IP Right Cessation
- 1998-06-08 EP EP98926418A patent/EP0983079B1/de not_active Expired - Lifetime
1999
- 1999-12-08 NO NO996035A patent/NO996035L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
SK169499A3 (en)	2001-03-12
CA2291645A1 (en)	1998-12-17
EP0983079A2 (de)	2000-03-08
JP2002504906A (ja)	2002-02-12
PT983079E (pt)	2005-06-30
AU7826298A (en)	1998-12-30
BR9810861A (pt)	2001-04-24
PL337779A1 (en)	2000-09-11
DE69829179D1 (de)	2005-04-07
EP0983079B1 (de)	2005-03-02
DE69829179T2 (de)	2005-07-21
NO996035D0 (no)	1999-12-08
TW505515B (en)	2002-10-11
IL132933A0 (en)	2001-03-19
ATE289821T1 (de)	2005-03-15
WO1998056398A3 (en)	1999-03-25
CN1264306A (zh)	2000-08-23
WO1998056398A2 (en)	1998-12-17
US5985823A (en)	1999-11-16

Legal Events

Date	Code	Title	Description
2004-02-02	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO996035D0 (no)	1999-12-08	Fremgangsmåte for behandling av diaré og for å eliminere enkelte bakteriepopulasjoner fra tykktarmen
DE69831506D1 (en)	2005-10-13	4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe
IL148079A0 (en)	2002-09-12	Human ctla-4 antibodies and compositions containing the same
DE69636228D1 (de)	2006-07-20	Therapeutische Zusammensetzungen zur Behandlung von Lawsonia intracellularis Infektionen
AP9200410A0 (en)	1992-07-31	Retroviral protease inhibitors.
NO976028D0 (no)	1997-12-22	Fremgangsmåte for kontroll av antibiotika resistente gram positive bakterier og behandling av infeksjon
ES2162039T3 (es)	2001-12-16	Nuevos ciclohexapeptidos antifungicos.
DE69631381D1 (de)	2004-02-26	Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
MX9708611A (es)	1998-02-28	Compuestos de dialquiltiacumicina.
CY2225B1 (en)	2003-04-18	Organic compounds
ATE201693T1 (de)	2001-06-15	Hämoregulierende peptide
ATE223226T1 (de)	2002-09-15	Azazyklohexapeptid-verbindungen
NO943765L (no)	1995-04-10	Aryloksybenzen-herbicidmidler
ES535471A0 (es)	1986-06-16	Procedimiento de un nuevo peptido como agente de proteccion contra el colera y-0 las gastroenteritis infecciosas.
BR9611520A (pt)	1999-12-28	Composto hemo-reguladores.